Development and Characterization of a Mucoadhesive System Containing Sodium Carboxymethylcellulose (CMC) as a Mucoadhesive Polymer

Abstract

This research focuses on the development and characterization of a mucoadhesive drug delivery system using sodium carboxymethylcellulose (CMC) as the primary mucoadhesive polymer. The study explores the formulation, optimization, and evaluation of the mucoadhesive properties, drug release profiles, and potential applications of the system. The results demonstrate that sodium CMC can effectively enhance mucoadhesion and provide a controlled release of the incorporated drug, making it a promising candidate for mucosal drug delivery.

Introduction

Mucoadhesive drug delivery systems have garnered significant interest due to their ability to adhere to mucosal surfaces, thereby extending the residence time of the drug at the site of absorption. This approach is particularly beneficial for drugs that experience extensive first-pass metabolism or require localized delivery to specific mucosal tissues. Sodium carboxymethylcellulose (CMC) is a derivative of cellulose known for its biocompatibility, biodegradability, and excellent mucoadhesive properties. It has been widely used in pharmaceutical formulations to enhance mucoadhesion and control drug release. This study aims to develop and characterize a mucoadhesive system using sodium CMC, evaluating its mucoadhesive strength, swelling behavior, and drug release profiles to assess its potential for various mucosal drug delivery applications. Sodium carboxymethylcellulose (CMC) has been extensively studied for its mucoadhesive properties in various drug delivery systems. (1) demonstrated that formulations containing sodium CMC exhibited excellent mucoadhesive profiles and reproducible results in the characterization of rosiglitazone maleate mucoadhesive microspheres. (2) explored the incorporation of CMC in thermosensitive and bioadhesive ophthalmic formulations, highlighting its role in enhancing mucoadhesion and drug release control. (3) reviewed natural polymers, including sodium CMC, emphasizing their potential to decrease drug release time and improve mucoadhesive strength . (4) developed mucoadhesive microspheres of metronidazole using sodium CMC, noting its significant impact on enhancing mucoadhesive properties and controlled drug release.(5)

Formulated a mucoadhesive budesonide solution for pediatric eosinophilic esophagitis using CMC as a mucoadhesive polymer, which effectively enhanced drug retention at the target site . 6()) evaluated an oral care gel containing Kaempferia galanga extract and CMC, demonstrating its superior mucoadhesive properties and potential for oral mucosal drug delivery . (8) characterized a caffeine-loaded oral transmucosal gel for neonates, utilizing sodium CMC to achieve desirable mucoadhesive and drug release characteristics. (9) investigated ocular mucoadhesive and biodegradable inserts for voriconazole delivery, where sodium CMC contributed to improved mucoadhesion and sustained drug release . (10) analyzed the mucoadhesive properties of interpolyelectrolyte complexes based on Eudragit® and CMC, confirming CMC’s effectiveness in enhancing mucoadhesion. (11) studied the physicochemical properties of plasticized amphotericin B-loaded sodium alginate and CMC-based films, highlighting CMC’s role in improving mucoadhesion and drug stability . Sodium carboxymethylcellulose (CMC) has been extensively studied for its mucoadhesive properties in various drug delivery systems. (12) developed mucoadhesive microspheres for cancer treatment using sodium CMC, which showed significant adherence to mucosal surfaces and effective drug delivery properties . formulated films based on sodium CMC for treating vaginal candidiasis, demonstrating enhanced mucoadhesive strength and controlled drug release.

Explored the incorporation of CMC in thermosensitive and bioadhesive ophthalmic formulations, highlighting its role in enhancing mucoadhesion and drug release control . (13) developed CMC-based hydrogels for bladder cancer treatment, showing that CMC significantly improved the mucoadhesive properties and drug retention at the target site.

Demonstrated that formulations containing sodium CMC exhibited excellent mucoadhesive profiles and reproducible results in the characterization of rosiglitazone maleate mucoadhesive microspheres . (14) reviewed natural polymers, including sodium CMC, emphasizing their potential to decrease drug release time and improve mucoadhesive strength. Thummala et al. (2023) enhanced the oral absorption of orlistat using gastroretentive mucoadhesive pellets containing sodium CMC, highlighting its role in improving drug bioavailability. (15) characterized novel mucoadhesive polymers for nasal drug delivery, with CMC showing excellent mucoadhesive properties and potential for improving drug retention in the nasal cavity .

(12) investigated the feasibility of intranasal delivery of mucoadhesive vaccine powders containing CMC, demonstrating its effectiveness in enhancing vaccine stability and mucoadhesion . (2) developed mucoadhesive microspheres of metronidazole using sodium CMC, noting its significant impact on enhancing mucoadhesive properties and controlled drug release.

Materials

Sodium carboxymethylcellulose (CMC): A biocompatible, biodegradable polymer used for its excellent mucoadhesive properties (4). Model drug (e.g., metformin): Selected for its therapeutic relevance and compatibility with CMC (3). Solvents (e.g., ethanol, water): Utilized for dissolving and processing the formulations (6). Buffer solutions (e.g., phosphate buffer): Used to simulate physiological conditions during experiments (9). Analytical reagents: Necessary for various analytical and characterization techniques

Parmar L, Masih P, Gupta N, Singh D. Development and Characterization of a Mucoadhesive System Containing Sodium Carboxymethylcellulose (CMC) as a Mucoadhesive Polymer. Journal of Heart Valve Disease. 2025 Jan;30(1):6-12.